chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 47.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Chills, Facial pain, Headache, Hypoaesthesia
Clinical narrative: right side facial pain; Right side jaw pain; Right side facial and arm tingling; Right side lip tingling; Right side of facial and arm numbness; Right side of lip numbness; fever 101-102+; arm pain; body aches; headache; nausea; chills; This is a spontaneous report from a contactable consumer, the patient. A 47-year-old non-pregnant female patient received her second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: 6206), via an unspecified route of administration in the left arm on 15Mar2021 at 14:30 (at the age of 47-year-old) as a single dose for COVID-19 immunisation. Medical history included pituitary adenoma. She was allergic to sulfa and codeine. Concomitant medications included Loestrin w Iron BC and cabergoline (MANUFACTURER UNKNOWN) taking for unknown indications and were received within 2 weeks of vaccination. The patient previously received first dose of BNT162b2(PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: unknown), via an unspecified route of administration in the left arm on 22Feb2021 at 14:30 (at the age of 47-year-old) as a single dose for COVID-19 immunisation. She did not receive any other vaccines within four weeks prior to the vaccination. Prior to the vaccination, she was not diagnosed with COVID-19. Since the vaccination, she had not been tested positive for COVID-19. On 16Mar2021, at 03:00, the patient experienced fever of 101-102 plus, arm pain, body aches, headache, nausea, and chills. On 16Mar2021, at 16:00 she took tylenol, one every 4 hours for 3 days as a treatment and most of the events were recovered by 17:00 to 18:00 on 16Mar2021. After 72 hours on 18Mar2021, she had experienced right side facial/jaw pain, right side facial/lip and arm tingling along with numbness and these reactions continued on-off all day, and were ongoing at the time of report. The patient did not receive any treatment for the events. The clinical outcome of the events fever, arm pain, body aches, headache, nausea, and chills were resolved on 16Mar2021 whereas, the clinical outcome of the events right side facial pain, right side jaw pain, right side facial and arm tingling, right side of facial and arm numbness and right side of lip numbness was unknown.  No follow-up attempts are needed. No further information is expected.
Age: 47.0
Sex: F
Vaccine: COVID19
Symptoms: Hypoaesthesia oral, Nausea, Pain, Pain in extremity, Pain in jaw
Clinical narrative: right side facial pain; Right side jaw pain; Right side facial and arm tingling; Right side lip tingling; Right side of facial and arm numbness; Right side of lip numbness; fever 101-102+; arm pain; body aches; headache; nausea; chills; This is a spontaneous report from a contactable consumer, the patient. A 47-year-old non-pregnant female patient received her second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: 6206), via an unspecified route of administration in the left arm on 15Mar2021 at 14:30 (at the age of 47-year-old) as a single dose for COVID-19 immunisation. Medical history included pituitary adenoma. She was allergic to sulfa and codeine. Concomitant medications included Loestrin w Iron BC and cabergoline (MANUFACTURER UNKNOWN) taking for unknown indications and were received within 2 weeks of vaccination. The patient previously received first dose of BNT162b2(PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: unknown), via an unspecified route of administration in the left arm on 22Feb2021 at 14:30 (at the age of 47-year-old) as a single dose for COVID-19 immunisation. She did not receive any other vaccines within four weeks prior to the vaccination. Prior to the vaccination, she was not diagnosed with COVID-19. Since the vaccination, she had not been tested positive for COVID-19. On 16Mar2021, at 03:00, the patient experienced fever of 101-102 plus, arm pain, body aches, headache, nausea, and chills. On 16Mar2021, at 16:00 she took tylenol, one every 4 hours for 3 days as a treatment and most of the events were recovered by 17:00 to 18:00 on 16Mar2021. After 72 hours on 18Mar2021, she had experienced right side facial/jaw pain, right side facial/lip and arm tingling along with numbness and these reactions continued on-off all day, and were ongoing at the time of report. The patient did not receive any treatment for the events. The clinical outcome of the events fever, arm pain, body aches, headache, nausea, and chills were resolved on 16Mar2021 whereas, the clinical outcome of the events right side facial pain, right side jaw pain, right side facial and arm tingling, right side of facial and arm numbness and right side of lip numbness was unknown.  No follow-up attempts are needed. No further information is expected.
Age: 47.0
Sex: F
Vaccine: COVID19
Symptoms: Paraesthesia, Paraesthesia oral, Pyrexia
Clinical narrative: right side facial pain; Right side jaw pain; Right side facial and arm tingling; Right side lip tingling; Right side of facial and arm numbness; Right side of lip numbness; fever 101-102+; arm pain; body aches; headache; nausea; chills; This is a spontaneous report from a contactable consumer, the patient. A 47-year-old non-pregnant female patient received her second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: 6206), via an unspecified route of administration in the left arm on 15Mar2021 at 14:30 (at the age of 47-year-old) as a single dose for COVID-19 immunisation. Medical history included pituitary adenoma. She was allergic to sulfa and codeine. Concomitant medications included Loestrin w Iron BC and cabergoline (MANUFACTURER UNKNOWN) taking for unknown indications and were received within 2 weeks of vaccination. The patient previously received first dose of BNT162b2(PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: unknown), via an unspecified route of administration in the left arm on 22Feb2021 at 14:30 (at the age of 47-year-old) as a single dose for COVID-19 immunisation. She did not receive any other vaccines within four weeks prior to the vaccination. Prior to the vaccination, she was not diagnosed with COVID-19. Since the vaccination, she had not been tested positive for COVID-19. On 16Mar2021, at 03:00, the patient experienced fever of 101-102 plus, arm pain, body aches, headache, nausea, and chills. On 16Mar2021, at 16:00 she took tylenol, one every 4 hours for 3 days as a treatment and most of the events were recovered by 17:00 to 18:00 on 16Mar2021. After 72 hours on 18Mar2021, she had experienced right side facial/jaw pain, right side facial/lip and arm tingling along with numbness and these reactions continued on-off all day, and were ongoing at the time of report. The patient did not receive any treatment for the events. The clinical outcome of the events fever, arm pain, body aches, headache, nausea, and chills were resolved on 16Mar2021 whereas, the clinical outcome of the events right side facial pain, right side jaw pain, right side facial and arm tingling, right side of facial and arm numbness and right side of lip numbness was unknown.  No follow-up attempts are needed. No further information is expected.
Age: 24.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Fatigue, Headache, Hyperhidrosis, Myalgia
Clinical narrative: Joint pain; Muscle soreness; Headache; Sweats; Fatigue; This is spontaneous report from a non-contactable consumer, the patient. A 24-year-old non-pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EP-7534), via an unspecified route of administration in the right arm on 17Mar2021 (at the age of 24-years-old), as a single dose for COVID-19 immunisation. Medical history included penicillin allergy. Concomitant medications included topiramate (MANUFACTURER UNKNOWN) and zolpidem (AMBIEN), both from an unknown date for unknown indication. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: unspecified), via an unspecified route of administration in the left arm on 24Feb2021 (at the age of 24-year-old) as a single dose for COVID-19 immunisation. The patient did not receive any other vaccine within 4 weeks, prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 17Mar2021 at 15:00, the patient experienced joint pain, muscle soreness, headache, sweats and fatigue. The patient did not receive treatment for joint pain, muscle soreness, headache, sweats and fatigue. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of joint pain, muscle soreness, headache, sweats and fatigue was not recovered at the time of report.   No follow-up attempts are possible. No further information is expected.
Age: 56.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Fatigue, Injection site atrophy, Lymph node pain, Myalgia
Clinical narrative: Moderate fever; chills; spasms at injection site; severe  muscle pain; lymph node pain; sore throat; fatigue; This is a spontaneous report received from a contactable consumer, the patient. A 56-year-old non-pregnant female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: Unknown) via an unspecified route of administration in her left arm on 17-MAR-2021 at 10:45 AM (at the age of 56-years-old), as a single dose for COVID-19 immunisation. The patient medical history included Type 2 diabetes, hypertension, high cholesterol, sleep apnoea, obesity. The patient past drug history was not reported. Concomitant medications included Amlodipine (MANUFACTURER UNKNOWN), Losartan (MANUFACTURER UNKNOWN) and Janumet (MANUFACTURER UNKNOWN) Lantus (MANUFACTURER UNKNOWN) Crestor (MANUFACTURER UNKNOWN) received within 2 weeks of vaccination. The patient had not received any other vaccines within 4 weeks prior to the COVID-19 vaccine. The patient had diagnosed with COVID-19 prior to vaccination. The patient had not been tested for COVID-19 since the vaccination. On 17Mar2021 6.00 PM the patient experienced moderate fever, chills, spasms at injection site, severe muscle pain, lymph node pain sore throat, and fatigue. The patient did not receive treatment for the reported events. The clinical outcome for Moderate fever, chills, spasms at injection site, severe muscle pain, lymph node pain, sore throat, and fatigue. was not recovered at the time of this report.   Information about lot/batch number cannot be obtained. No further information is expected.
Age: 56.0
Sex: F
Vaccine: COVID19
Symptoms: Oropharyngeal pain, Pyrexia
Clinical narrative: Moderate fever; chills; spasms at injection site; severe  muscle pain; lymph node pain; sore throat; fatigue; This is a spontaneous report received from a contactable consumer, the patient. A 56-year-old non-pregnant female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: Unknown) via an unspecified route of administration in her left arm on 17-MAR-2021 at 10:45 AM (at the age of 56-years-old), as a single dose for COVID-19 immunisation. The patient medical history included Type 2 diabetes, hypertension, high cholesterol, sleep apnoea, obesity. The patient past drug history was not reported. Concomitant medications included Amlodipine (MANUFACTURER UNKNOWN), Losartan (MANUFACTURER UNKNOWN) and Janumet (MANUFACTURER UNKNOWN) Lantus (MANUFACTURER UNKNOWN) Crestor (MANUFACTURER UNKNOWN) received within 2 weeks of vaccination. The patient had not received any other vaccines within 4 weeks prior to the COVID-19 vaccine. The patient had diagnosed with COVID-19 prior to vaccination. The patient had not been tested for COVID-19 since the vaccination. On 17Mar2021 6.00 PM the patient experienced moderate fever, chills, spasms at injection site, severe muscle pain, lymph node pain sore throat, and fatigue. The patient did not receive treatment for the reported events. The clinical outcome for Moderate fever, chills, spasms at injection site, severe muscle pain, lymph node pain, sore throat, and fatigue. was not recovered at the time of this report.   Information about lot/batch number cannot be obtained. No further information is expected.
Age: 61.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, SARS-CoV-2 test
Clinical narrative: Dizziness; This is a spontaneous report received from a contactable consumer, the patient. A 61-year-old non-pregnant female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EN6202), via an unspecified route of administration in left arm on 04Mar2021 (at the age of 61-years-old), as a single dose for COVID-19 immunisation. Medical history included thyroid removal. The patient was allergic to shingles vaccine. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included hormones (MANUFACTURER UNKNOWN), levothyroxine (MANUFACTURER UNKNOWN), magnesium (MANUFACTURER UNKNOWN), melatonin (MANUFACTURER UNKNOWN) and vitamin (MANUFACTURER UNKNOWN) all for unknown indication from unknown dates. The patient did not receive any other vaccines within 4 weeks prior to the COVID -19 vaccination. Since the vaccination, the patient was tested for COVID-19.  On 06Mar2021, the patient experienced dizziness which started two days later had not resolved. On 17Mar2021, the patient underwent nasal swab test for COVID-19 and the result was negative. The event dizziness is resulted in doctor or other healthcare professional office/clinic visit. The patient did not receive any treatment for the event dizziness. The clinical outcome of event dizziness was not resolved.    No follow-up attempts are needed. No further information is expected.
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: Tooth infection
Clinical narrative: Tooth infection; This is a spontaneous report from a contactable consumer (patient). A 62-years-old female patient received bnt162b2 (PFIZER-BIONTECH mRNA COVID-19 VACCINE, Formulation: Solution for injection, Lot Number: EN6205), dose 1 via an unspecified route of administration, administered in arm right on 02Mar2021 at 18:45 (at the age of 62-years-old) as single for COVID-19 immunisation. Medical history included ongoing atrial fibrillation from 2012 (has had AFIB for 9 years now). There was no history of previous immunization with the Pfizer vaccine considered as suspect. The patient did not administer additional vaccines on same date of the Pfizer suspect and did not receive prior vaccinations within 4 weeks. The patient was not taking any concomitant medications. On 11Mar2021, the patient experienced tooth infection. On 13Mar2021, the patient started Amoxicilllin 500mg for 10 days with instructions to take 1 capsule every 8 hours. She was still taking the Amoxicillin as of 16Mar2021. She reported that she should finished with the Amoxicillin before she gets her second COVID-19 vaccine shot on 25Mar2021. She was scheduled for a root canal on 22Mar2021, and would be done with the Amoxicillin by that time. She asked if being on the Amoxicillin will effect her second COVID-19 vaccine dose. The patient did not visit emergency room or physician office due to the event. The outcome of the event was resolving.  No follow-up attempts are possible. No further information is expected.
Age: 30.0
Sex: M
Vaccine: COVID19
Symptoms: Tinnitus
Clinical narrative: Terrible tinnitus; This is a spontaneous report received from a contactable consumer, the patient.  A 30-year-old male patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: unknown) via an unspecified route of administration in the left arm on 18Mar2021 at 15:00 (at the age of 30 years old) as a single dose for COVID-19 immunisation.  Medical history included diabetes and high blood pressure.  The patient did not have any allergies to food, medication or other products. The patient did not receive any other vaccines within 4 weeks prior to the COVID-19 vaccine. Prior to the vaccination, the patient was not diagnosed with COVID-19 and had not been tested positive for COVID-19, since the vaccination.  Concomitant medications include NOVOLOG, OZEMPIC and insulin glargine.  On 16Mar2021 at 04:30, the patient woke up with terrible tinnitus.  The patient did not receive any treatment for tinnitus.  The clinical outcome of tinnitus was resolving. No follow-up attempts are needed. No further information is expected.
Age: 62.0
Sex: M
Vaccine: COVID19
Symptoms: Hypoaesthesia
Clinical narrative: numbness in left toes - mainly  middle toes; This is a spontaneous report from a contactable consumer, the patient. A 62-year-old male patient received BNT162B2 (PFIZER BIONTECH COVID-19 mRNA VACCINE; Lot number; unknown) via an unspecified route of administration into left arm as first single dose for COVID-19 immunisation on 18Mar2021 at 10:30 (at the age of 62 years). Prior to vaccination, patient was not diagnosed with COVID-19, Since the vaccination, patient had not been tested for COVID-19. The patient had allergies from dust mites and grass. Concomitant medications included nexum (MANUFACTURER UNKNOWN) for unknown indication started from unknown date, floranase (MANUFACTURER UNKNOWN) for unknown indication started from unknown date, florachrome (MANUFACTURER UNKNOWN) for unknown indication started from unknown date, alegra (MANUFACTURER UNKNOWN) for unknown indication started from unknown date. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. On 18Mar2021 at 16:00, the patient experienced event numbness in left toes, mainly on middle toes. The clinical outcome of the event numbness in left toes was not recovered at the time of report.  No follow-up attempts are needed; information about lot number cannot be obtained.
Age: 58.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Headache, Myalgia, Nausea, Pyrexia
Clinical narrative: Nausea; Vomiting; Chills; Fever; Headache; Muscle aches; This is a spontaneous report from a non-contactable other health care professional. A 58-year-old non pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EL3247) via unspecified route administered in left arm on 17Mar2021 at 14:30 (at the age of 58-years-old) as a single dose for COVID-19 immunisation. Medical history included high blood pressure, low thyroid and breast cancer. The patient was allergic to penicillin and levaquin. Concomitant medications included lisinopril (MANUFACTURER UNKNOWN), levothyroxine (MANUFACTURER UNKNOWN), letrozole (MANUFACTURER UNKNOWN), low-dose aspirin ((MANUFACTURER UNKNOWN) and multivitamin (MANUFACTURER UNKNOWN). The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EL3247), via unspecified route administered in left arm on 23Feb2021 at 15:00 as a single dose for COVID-19 immunisation. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not tested for COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. On 18Mar2021, approximately 24 hours after receiving the vaccination, the patient experienced nausea, vomiting, chills, fever, headache and muscle aches. All events began to subside within 18 hours but still present. Therapeutic measures were taken as a result of nausea, vomiting, chills, fever, headache and muscle aches and included treatment with water, ibuprofen and rest. The clinical outcome of the events nausea, vomiting, chills, fever, headache and muscle aches were resolving.   No follow-up attempts are needed. No further information is expected.
Age: 58.0
Sex: F
Vaccine: COVID19
Symptoms: Vomiting
Clinical narrative: Nausea; Vomiting; Chills; Fever; Headache; Muscle aches; This is a spontaneous report from a non-contactable other health care professional. A 58-year-old non pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EL3247) via unspecified route administered in left arm on 17Mar2021 at 14:30 (at the age of 58-years-old) as a single dose for COVID-19 immunisation. Medical history included high blood pressure, low thyroid and breast cancer. The patient was allergic to penicillin and levaquin. Concomitant medications included lisinopril (MANUFACTURER UNKNOWN), levothyroxine (MANUFACTURER UNKNOWN), letrozole (MANUFACTURER UNKNOWN), low-dose aspirin ((MANUFACTURER UNKNOWN) and multivitamin (MANUFACTURER UNKNOWN). The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EL3247), via unspecified route administered in left arm on 23Feb2021 at 15:00 as a single dose for COVID-19 immunisation. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not tested for COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. On 18Mar2021, approximately 24 hours after receiving the vaccination, the patient experienced nausea, vomiting, chills, fever, headache and muscle aches. All events began to subside within 18 hours but still present. Therapeutic measures were taken as a result of nausea, vomiting, chills, fever, headache and muscle aches and included treatment with water, ibuprofen and rest. The clinical outcome of the events nausea, vomiting, chills, fever, headache and muscle aches were resolving.   No follow-up attempts are needed. No further information is expected.
Age: 26.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Fatigue, Myalgia, Pyrexia, Rash
Clinical narrative: Fever; muscle aches; chills; fatigue; rash on arms; This is a spontaneous report received from a contactable consumer, the patient. A 26-year-old non-pregnant female patient received her second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: Unknown) via an unspecified route of administration in left arm on 17Mar2021 at 13:15 (at the age of 26-year-old) as a single dose, for COVID-19 immunisation. Medical history was not reported. The patient received birth control (MANUFACTURER UNKNOWN) within 2 weeks of vaccination. The patient previously received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: Unknown), via an unspecified route of administration in left arm on 24Feb2021 at 00:00 hours (at the age of 26-year-old), as a single dose for COVID-19 immunisation. Prior to vaccination the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID-19 vaccine. Since the vaccination patient had not been tested for COVID-19. The patient had codeine allergies. On 18Mar2021, the patient experienced fever, muscle aches, chills, fatigue and rash on arms. The patient did not receive any treatment for events. The clinical outcome of the events fever, muscle aches, chills, fatigue and rash on arms were recovering.  No follow-up attempts are needed. No further information is expected
Age: 29.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Back pain, Malaise, Pain in extremity
Clinical narrative: Arm is really sore. Hurts to lift; I had aches and pains in my upper backand shoulders; Joint pains in my wrist; I felt sick for 5 min and I had to lay down; I had aches and pains in my upper backand shoulders; This is a spontaneous report from a contactable consumer, the patient. A 29-year-old non-pregnant female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot Number: EN6205), via an unspecified route of administration in the left arm on 18Mar2021 at 09:00 (at the age of 29-years-old) as single dose for COVID-19 immunisation. Medical history included COVID-19 prior to vaccination. The patient was allergic to zithromax (MANUFACTURE UNKNOWN) since an unspecified date. Concomitant medications were not reported. The patient was not tested for COVID-19 since having the vaccine. On 19Mar2021 at 07:15, the patient experienced really sore arm which had hurt to lift. She had aches and pains in her upper back and shoulders and also had joint pains with her wrist. The patient felt sick for 5 min and then had to lay down. No treatment was taken for the reported events. The clinical outcome of the events pain in arm, shoulder pain, wrist pain, feeling sick and upper back pain was resolving at the time of the report. No follow-up attempts are needed. No further information is expected.
Age: 66.0
Sex: M
Vaccine: COVID19
Symptoms: Blood blister
Clinical narrative: Blood filled small blister; This is a spontaneous report from a contactable patient. A 66 years old male patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot no: Unknown), via an unspecified route of administration in left arm on 04Mar2021 at 00:00 as a single dose for COVID-19 immunisation (at the age of 66 years). Patients medical history included high blood pressure. The patient previously received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot no: Unknown), via an unspecified route of administration in left arm on 21Jan2021 at 00:00 as a single dose for COVID-19 immunisation and the events are not reported . The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient did not receive any other medication within 2 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, patient has not tested positive for COVID-19. The patient reported no allergies to medications, food, or other products. The patient experienced blood blister on 18Mar2021 at 00:00. The patient reported that area of blister has spread slightly. Therapeutic measures were not taken. The clinical outcome of blood blister was not resolved at the time of the report.   No follow-up attempts are possible; information about lot number cannot be obtained.
Sex: F
Vaccine: COVID19
Symptoms: SARS-CoV-2 test, Streptococcal infection
Clinical narrative: strep infection; This is a spontaneous report from a Pfizer-sponsored program from a contactable consumer (patient). A female patient of an unspecified age, received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, lot number and expiry dates were not provided), via an unspecified route of administration, on an unknown date, as a single dose for COVID-19 immunisation. Patient's medical history and concomitant medications were not reported. Patient reported that she was scheduled to receive her second dose of Pfizer-BioNTech Covid19 vaccine today/tomorrow. She has recently been diagnosed with a strep infection, and was being treated with "amox/clav 875mg twice a day" and wanted to see if there was an interaction between the antibiotic and the vaccine. On an unknown date, she underwent a COVID test which came back as negative. She wanted to know what would happen if she was unable to receive her second dose, tomorrow?. Outcome of the event was unknown.   No follow-up attempts are possible; information about lot/batch number cannot been obtained.
Age: 48.0
Sex: F
Vaccine: COVID19
Symptoms: Disturbance in attention, Fatigue, Feeling abnormal, Vaccination site erythema, Vaccination site pruritus
Clinical narrative: Very fatigued; Foggy brained difficulty focusing; swelling, redness and itching at the shot location; swelling, redness and itching at the shot location; swelling, redness and itching at the shot location; Foggy brained difficulty focusing; This is a spontaneous report received from a contactable consumer, the patient. A 48-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot number: EN6208) via an unspecified route of administration on left arm on 16Mar2021 at 12 hours (at the age of 48-year-old) as a single dose for COVID-19 immunisation. The medical history included known allergies of nutmeg, cayenne and lactose intolerant, autoimmune graves and hashimotos. The concomitant medications were not reported. The patient had not received any other vaccines within 4 weeks prior to the COVID vaccine. On 16Mar2021 at 17 hours, the patient felt very fatigued for approximately 36 hours after the vaccination and foggy brain, difficulty focusing, swelling, redness and itching at the shot location. Prior to vaccination, the patient was not diagnosed with COVID-19 and patient was not tested for COVID-19 since the vaccination. No treatment medications were taken for the reported events. The clinical outcome of the events was recovered on unknown date in Mar2021.  No follow-up attempts are needed. No further information is expected.
Age: 48.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site swelling
Clinical narrative: Very fatigued; Foggy brained difficulty focusing; swelling, redness and itching at the shot location; swelling, redness and itching at the shot location; swelling, redness and itching at the shot location; Foggy brained difficulty focusing; This is a spontaneous report received from a contactable consumer, the patient. A 48-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot number: EN6208) via an unspecified route of administration on left arm on 16Mar2021 at 12 hours (at the age of 48-year-old) as a single dose for COVID-19 immunisation. The medical history included known allergies of nutmeg, cayenne and lactose intolerant, autoimmune graves and hashimotos. The concomitant medications were not reported. The patient had not received any other vaccines within 4 weeks prior to the COVID vaccine. On 16Mar2021 at 17 hours, the patient felt very fatigued for approximately 36 hours after the vaccination and foggy brain, difficulty focusing, swelling, redness and itching at the shot location. Prior to vaccination, the patient was not diagnosed with COVID-19 and patient was not tested for COVID-19 since the vaccination. No treatment medications were taken for the reported events. The clinical outcome of the events was recovered on unknown date in Mar2021.  No follow-up attempts are needed. No further information is expected.
Age: 38.0
Sex: M
Vaccine: COVID19
Symptoms: Fatigue, Influenza like illness, Malaise, Myalgia, Pain in extremity
Clinical narrative: Significant pain in the injected arm; muscle ache; general malaise; Fatigue; flu/cold like symptoms; This is a spontaneous report from a contactable consumer, the patient. A 38-year old male patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EL3247), via an unspecified route of administration in the left arm on 18Mar2021 at 10:45 (at the age of 38-years-old), as a single dose for COVID-19 immunisation. Medical history and concomitant medication were not reported and the patient had no known allergies. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EL3247), via an unspecified route of administration in the left arm on 23Feb2021 at 10:00 (at the age of 38-year-old), as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 19Mar2021 at 08:00, patient experienced significant pain in the injected arm, muscle aches, general malaise, fatigue, and flu/cold like symptoms. No drugs were taken for the treatment of significant pain in the injected arm, muscle aches, general malaise, fatigue, and flu/cold like symptoms. The clinical outcome of pain in arm, muscle aches, general malaise, fatigue, and flu like symptoms was recovering at time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 73.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Chills, Neck pain, Pyrexia
Clinical narrative: fever; chills; sore neck; This is a spontaneous report received from a contactable consumer, the patient. A 73-year-old non-pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: unknown) via an unspecified route of administration in her left arm on 18Mar2021 at 1200 (at the age of 73-years-old), as a single dose for COVID-19 immunisation. The patient medical history was none. Concomitant medications was not reported. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: unknown) via an unspecified route of administration in left arm on 25Feb2021 at 1200 (at the age of 73-years-old), as a single dose for COVID-19 immunisation. The patient had not received any other vaccines within 4 weeks prior to the COVID-19 vaccine. Prior to vaccination the patient was not diagnosed with COVID-19. Since the vaccination the patient had not been tested for COVID-19. The patient had no allergies to medications, food, or other products. On 18Mar2021 at 2330 the patient experienced chills, fever, and a sore neck. It was reported that the patient had chills, a fever of 101(units unspecified) and a sore neck for 6 hours, beginning at 2330 and continuing until 0530 the next morning. The patient did not receive any treatment for the reported events. The clinical outcome for chills, fever and a sore neck were recovered on 19Mar2021 at 0530.   Information about lot/batch number cannot be obtained. No further information is expected.
Age: 53.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal discomfort, Eructation, Headache, Malaise, Nausea
Clinical narrative: excessive burping.; Experiencedmore serious GI discomfort 3 days; nausea; Body aches; Mild fever; Mild headache; Malaise; This is a spontaneous report from a non-contactable consumer, the patient. A 53-year-old non-pregnant female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: UNKNOWN) as a single dose via unspecified route of administration in left arm on 13Mar2021 at 14:00 (at the age of 53-year-old) for COVID-19 immunisation. Medical history included GERD (Gastroesophageal reflux disease). Concomitant medications included multivitamin (MANUFACTURER UNKNOWN), fish oil (MANUFACTURER UNKNOWN), calcium (MANUFACTURER UNKNOWN) taken within two weeks of vaccination. The patient had no allergies to medications, food or other products. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient had not been tested positive for COVID-19 since the vaccination. The patient did not received any other vaccines within 4 weeks prior to the COVID vaccine. On 15Mar2021 at 12:00, the patient experienced mild fever, mild headache, body aches, malaise and typical GERD (Gastroesophageal reflux disease) symptoms of nausea and excessive burping. Experienced more serious GI discomfort 3 days after vaccine but no need to hospitalized. Patient did not receive any treatment for adverse events. The clinical outcome of mild fever, mild headache, body aches, malaise, nausea and excessive burping was recovering. No further information is expected. Information about lot/batch number cannot be obtained.
Age: 53.0
Sex: F
Vaccine: COVID19
Symptoms: Pain, Pyrexia
Clinical narrative: excessive burping.; Experiencedmore serious GI discomfort 3 days; nausea; Body aches; Mild fever; Mild headache; Malaise; This is a spontaneous report from a non-contactable consumer, the patient. A 53-year-old non-pregnant female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: UNKNOWN) as a single dose via unspecified route of administration in left arm on 13Mar2021 at 14:00 (at the age of 53-year-old) for COVID-19 immunisation. Medical history included GERD (Gastroesophageal reflux disease). Concomitant medications included multivitamin (MANUFACTURER UNKNOWN), fish oil (MANUFACTURER UNKNOWN), calcium (MANUFACTURER UNKNOWN) taken within two weeks of vaccination. The patient had no allergies to medications, food or other products. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient had not been tested positive for COVID-19 since the vaccination. The patient did not received any other vaccines within 4 weeks prior to the COVID vaccine. On 15Mar2021 at 12:00, the patient experienced mild fever, mild headache, body aches, malaise and typical GERD (Gastroesophageal reflux disease) symptoms of nausea and excessive burping. Experienced more serious GI discomfort 3 days after vaccine but no need to hospitalized. Patient did not receive any treatment for adverse events. The clinical outcome of mild fever, mild headache, body aches, malaise, nausea and excessive burping was recovering. No further information is expected. Information about lot/batch number cannot be obtained.
Age: 61.0
Sex: M
Vaccine: COVID19
Symptoms: Urticaria
Clinical narrative: hives on my stomach, side, arms, thighs; This is a spontaneous report from a contactable consumer, the patient. A 61-year-old adult female patient received her unknown dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot number: unknown) via an unspecified route of administration in the left arm on 11Mar2021 at 11:15 (at the age of 61-years-old), as a single dose for COVID-19 immunisation. The patients medical history was not reported. The patient had allergies to various antibiotics, shellfish, bees, honey & other medicine additives. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. Concomitant medications were not reported. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccine. On 16Mar2021, the patient experienced hives 4-5 days later, on stomach, side, arms & thighs. The patient received benadryl & prednisone for the adverse events. The clinical outcome of the events hives on stomach, side, arms & thighs were not recovered at the time of this report.    Information about lot/batch number cannot be obtained. No further information is expected.
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Nausea
Clinical narrative: Nausea; Headache; This is a spontaneous report from a contactable consumer, the patient. A 66-year-old non-pregnant female patient received an unknown dose number of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EN6203), via an unspecified route of administration to the right arm on 07Mar2021 at 1245 (at the age of 66-years-old), as a single dose for COVID-19 immunisation. Medical history was not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient previously received a dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EM9809,), via an unspecified route of administration to the arm on 14Feb2021, as a single dose for COVID-19 immunisation. Concomitant medications included crestor (MANUFACTURE UNKNOWN), mvi (MANUFACTURE UNKNOWN), calcium (MANUFACTURE UNKNOWN) and vit D3 (MANUFACTURE UNKNOWN). On 07Mar2021 at 1900, the patient experienced nausea and headache. The events resulted in a visit to the doctor/ other health care professional. No therapeutic measures were taken. Since the vaccination, the patient had not tested for COVID-19. The clinical outcomes of the events of nausea and headache were recovering at the time of reporting.   No follow-up attempts are needed. No further information is expected.
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal pain upper, Diarrhoea, Fatigue, Headache, Pain in extremity
Clinical narrative: Stomach cramps; Headache; Arm hurt; Diarrhea; Fatigue; This is a spontaneous report from a contactable consumer, the patient.  A 71-year-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: OEN6208) via unspecified route of administration in left arm on 13Mar2021 at 16:00 (at the age of 71-year-old) as a single dose for COVID-19 immunisation.  Medical history included asthma, rectal cancer, cervical cancer, allergies. The patient was allergic to sulfa, penicillin, ceclor, wheat, yeast, malt. Past drug history included ceclor had taken from an unspecified date. Concomitant medications included renew life probiotics (MANUFACTURER UNKNOWN), Buspirone (MANUFACTURER UNKNOWN), Montelucast (MANUFACTURER UNKNOWN), ZIO had taken within two weeks of vaccination for an unknown indication. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested positive for COVID-19. It was reported that the patient did not received any other vaccines within 4 weeks prior to the COVID vaccine. On 14Mar2021 at 12:00, the patient experienced headache, arm hurt, stomach cramps, diarrhea, fatigue. No treatment was received for the events. The clinical outcome of headache, arm hurt, stomach cramps, diarrhea, fatigue was recovered on an unspecified date.   No follow-up attempts are needed. No further information is expected.
Age: 25.0
Sex: M
Vaccine: COVID19
Symptoms: Headache, Myalgia
Clinical narrative: This is a spontaneous report from a contactable consumer, the patient. A 25-year-old male patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; lot number: EP6955) administered in the left arm on 18Mar2021 at 10:00 (at the age of 25-year-old) as a single dose for COVID-19 immunisation. The patient's medical history included asthma, high blood pressure and hypothyroidism. The patient did not receive any other vaccine within 4 weeks prior to the COVID-19 vaccine. Concomitant medications included enalapril (MANUFACTURE UNKNOWN), levothyroxine (MANUFACTURE UNKNOWN), albuterol (MANUFACTURE UNKNOWN). The patient was allergic to amoxicillin. The patient was not diagnosed with COVID-19 prior to vaccination. The patient had not been tested for COVID-19 since having the vaccine. On 18Mar2021 at 0100 hours, the patient experienced generalised muscle aches and headache. The patient reported muscle pain throughout entire body, including lower back, arms, and legs and very very mild headache which was noticeable only if paid attention. The patient did not receive any treatment for the events. The clinical outcome for generalised muscle aches and headache was not resolved.   Information about lot/batch number cannot be obtained. No further information is expected.
Age: 51.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Headache, Oropharyngeal pain, Pyrexia, Rash
Clinical narrative: Headache; Mild fever; Mild sore throat; Tiredness; Body rash; This is a spontaneous report from a contactable consumer, the patient. A 51-year-old non-pregnant female patient received her first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot number: UNKNOWN), via an unspecified route of administration in the left arm on 17Mar2021 at 17:00 (at the age of 51-years-old), as a single dose for COVID-19 immunisation. Medical history was not reported. Concomitant medication included prozac (MANUFACTURER UNKNOWN) for an unknown indication from an unspecified date and unknown if ongoing. Patient did not have any allergies to food, medications, or other products. Prior to the vaccination, the patient was diagnosed with COVID-19. Since the vaccination, the patient had not been tested positive for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Patient was not pregnant. The patient had not tested positive for COVID-19 since the vaccination. On 17Mar2021 at 17:00, the patient experienced headache, mild fever, mild sore throat, tiredness and body rash more than 24 hours after injections. Patient did not receive any treatment for the events. The clinical outcomes of the events headache, mild fever, mild sore throat, tiredness, body rash were recovered.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia, Diarrhoea, Fatigue, Feeling abnormal
Clinical narrative: Loose bowels to diarrheas; shoulder pain in joint, right arm; fatigue; brain fog; This is a spontaneous report from a contactable consumer, the patient. A 73-year-old male patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot number: EL 9266) via an unspecified route of administration in his right arm on 19Feb2021 at 11:00 AM as single dose for COVID-19 immunisation. The patients medical history includes that of previous tonsillar cancer treated and clear. Patient was allergic to cipro and tomatoes. He previously received first dose of BNT162B2 via an unspecified route of administration on an unspecified date as single dose for COVID-19 immunisation. The patient had received other medications within 2 weeks of vaccination. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient did not have COVID-19 prior to vaccination. He had not tested positive for COVID-19 since the vaccine. On 20Feb2021 at 09:00 AM, the patient experienced loose bowels to diarrhea, shoulder pain in joint, right arm, fatigue and brain fog. Patient did not receive any treatment for events. The clinical outcome of all events was not recovered at the time of report.   No follow-up attempts are needed. No further information is expected.
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal discomfort, Arthralgia, Asthenia, Dizziness, Headache
Clinical narrative: stomach upset; Joint ache; Body aches; headache; weakness; dizziness; This is a spontaneous report from a contactable consumer, the patient. A 72-year-old non-pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: unknown), via an unspecified route of administration, in left arm on 16Mar2021 at 12:30 (at the age of 72-years-old), as single dose for COVID-19 immunisation. Medical history included asthma and type 2 diabetes. The patient had allergic history to penicillin and also some adverse stomach reaction to antibiotics. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: unknown) via an unspecified route of administration on 23Feb2021. Concomitant medications included ADVAIR, metformin (MANUFACTURER UNKNOWN), CRESTOR, diltiazem (MANUFACTURER UNKNOWN), EFFEXOR, all for unknown indication from an unknown date. The patient had received other vaccines within four weeks prior to the vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 16Mar2021, the patient had experienced body aches, headache, weakness and dizziness. On 18Mar2021, the patient had experienced joint aches and stomach upset. No therapeutic measures were taken for the events reported. The clinical outcome of the events body aches, headache, weakness, dizziness, joint aches and stomach upset were recovering at the time of reporting.   Information about lot number cannot be obtained. No further information is expected.
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: Pain
Clinical narrative: stomach upset; Joint ache; Body aches; headache; weakness; dizziness; This is a spontaneous report from a contactable consumer, the patient. A 72-year-old non-pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: unknown), via an unspecified route of administration, in left arm on 16Mar2021 at 12:30 (at the age of 72-years-old), as single dose for COVID-19 immunisation. Medical history included asthma and type 2 diabetes. The patient had allergic history to penicillin and also some adverse stomach reaction to antibiotics. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: unknown) via an unspecified route of administration on 23Feb2021. Concomitant medications included ADVAIR, metformin (MANUFACTURER UNKNOWN), CRESTOR, diltiazem (MANUFACTURER UNKNOWN), EFFEXOR, all for unknown indication from an unknown date. The patient had received other vaccines within four weeks prior to the vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 16Mar2021, the patient had experienced body aches, headache, weakness and dizziness. On 18Mar2021, the patient had experienced joint aches and stomach upset. No therapeutic measures were taken for the events reported. The clinical outcome of the events body aches, headache, weakness, dizziness, joint aches and stomach upset were recovering at the time of reporting.   Information about lot number cannot be obtained. No further information is expected.